Lupin Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Lupin Establishes a New Global Standard in Sustainable Pharma with an S&P Global ESG Score of 91".
LUPIN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lupin Limited has informed the stock exchange about a press release highlighting its S&P Global ESG Score of 91, which the company describes as establishing a new global standard in sustainable pharma. The score reflects strong performance across environmental, social, and governance parameters assessed by S&P Global. This positions Lupin among the top-rated pharmaceutical companies globally on ESG metrics. The announcement is informational and does not involve any financial transaction, dividend, or corporate action.
Limited direct impact on stock price, but reinforces Lupin's reputation with ESG-focused institutional investors and funds that screen for sustainability metrics, potentially supporting long-term valuation and global investor interest.